One of these patients, determined with LZTR1 variant rs869320686 p.(Gly248Arg), developed a myelodysplastic syndrome (MDS) 2.1 years after undergoing hyperdiploid pre B-cell ALL. The gene discussed is LZTR1; the disease is myelodysplastic syndrome.